# Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Healthy Subjects

> **NCT01520831** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 35 (actual)

## Conditions studied

- Diabetes
- Healthy

## Interventions

- **DRUG:** biphasic insulin aspart 30
- **DRUG:** biphasic insulin aspart 50
- **DRUG:** biphasic insulin aspart 70
- **DRUG:** insulin aspart

## Key facts

- **NCT ID:** NCT01520831
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-04
- **Primary completion:** 2000-05
- **Final completion:** 2000-05
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2017-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01520831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01520831, "Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01520831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*